LAB vs MAS · rev $174.4M vs P/E 18, rev $7.83B
Standard Biotools Inc (LAB) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
LAB currently screens at market cap $317.1M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the LAB and MAS stock pages for the full models.
Not investment advice.